Concepedia

Author

Andrea Hruštincová

Institute of Haematology and Blood TransfusionORCID

Also Known As

A. HRUŠTINCOVÁ, A. Hrustincova, A. Hruštincová, ANDREA HRUSTINCOVA, Andrea Hrustincova, Andrea Hruštincová

26

Publications

225

Citations

10

H-Index

9

Concepts

All Affiliations

Institute of Haematology and Blood TransfusionGeneral University Hospital in PragueCharles UniversityCzech Technical University in Prague
AH

About

Andrea Hruštincová is an author at Institute of Haematology and Blood Transfusion specializing in immunology, hematology, and gene expression.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

17

2

Cell Biology

1

1

17

3

Immunology

1

1

17

4

Pathology

1

1

17

5

Epigenetics

1

1

17

Andrea Hruštincová

×

9

Publications

189

Citations

9

H-Index

YearCitations

Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome

Andrea Hruštincová, Zdeněk Krejčík, Dávid Kundrát,

Cells

2020

40

LncRNA Profiling Reveals That the Deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 Is Associated with Higher-Risk Myelodysplastic Syndrome

Katarína Szikszai, Zdeněk Krejčík, Nikoleta Loudová,

Cancers

2020

26

Genome‐wide mi<scp>RNA</scp> profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide

Michaela Dostálová Merkerová, Zdeněk Krejčík, Monika Beličková,

European Journal Of Haematology

2014

22

MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia

Zdeněk Krejčík, Monika Beličková, Andrea Hruštincová,

Cancer Biomarkers

2018

22

Microarray profiling defines circulating microRNAs associated with myelodysplastic syndromes

Michaela Dostálová Merkerová, Andrea Hruštincová, Zdeněk Krejčík,

Neoplasma

2017

20

Aberrant expression of the microRNA cluster in 14q32 is associated with del(5q) myelodysplastic syndrome and lenalidomide treatment

Zdeněk Krejčík, Monika Beličková, Andrea Hruštincová,

Cancer Genetics

2015

17

Relationship between Altered miRNA Expression and DNA Methylation of the DLK1-DIO3 Region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related Changes

Michaela Dostálová Merkerová, Hana Remešová, Zdeněk Krejčík,

Cells

2018

17

Expression of circular <scp>RNAs</scp> in myelodysplastic neoplasms and their association with mutations in the splicing factor gene <i>SF3B1</i>

Iva Trsová, Andrea Hruštincová, Zdeněk Krejčík,

Molecular Oncology

2023

15

Noncoding RNAs and Their Response Predictive Value in Azacitidine-treated Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-related Changes

Michaela Dostálová Merkerová, Dávid Kundrát, Katarína Szikszai,

Cancer Genomics & Proteomics

2022

10

Page 1